Vimarsana
Biggest News Aggregation in the World

Page 3 - Shape Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shape Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shape Therapeutics Today - Breaking & Trending Today

Seven Biopharma Trends to Watch in 2023 - Vimarsana News

Seven Biopharma Trends to Watch in 2023

Key trends include fewer and slower financings, a surge of decisive data readouts for cancer vaccines, and further development of mRNA, cell, and gene therapies.

Lilly pays $75M to widen RNA editing deal with ProQR - Vimarsana News

Lilly pays $75M to widen RNA editing deal with ProQR

BioPharma

Reclaim.ai Closes $9.5M in Total Funding - Vimarsana News

Reclaim.ai Closes $9.5M in Total Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Ascidian starts up with $50M and a twist on RNA editing - Vimarsana News

Ascidian starts up with $50M and a twist on RNA editing

BioPharma

Harvard Business School Announces 2022-2023 Kaplan Fellows - Vimarsana News

Harvard Business School Announces 2022-2023 Kaplan Fellows

Harvard Business School (HBS) has announced this year’s recipients of the Robert S. Kaplan (MBA 1983) Life Sciences Fellowship. Established in 2008, the fellowship was created by Robert S. Kaplan, who served as president and chief executive officer of the Federal Reserve Bank of Dallas, vice chairman of the Goldman Sachs Group, Inc., and was the Martin Marshall Professor of Practice at HBS.

Source: hbs.edu